Table 2.

Medications and co-morbidities at baseline. Data are presented as medians (P₂₅, P₇₅) or proportions (%).

	Non-fallers (n=69)	Fallers (n=32)	p-value
Medications (n)	5 (3 to 8)	8 (6 to 10.5)	0.001*
Medication type (%)
Psychotropic	14 (20.3%)	9 (28.1%)	0.4
Peripheral nervous	1 (1.4%)	3 (9.4%)	0.06
Analgesic	20 (29%)	13 (40.6%)	0.2
Renal	3 (4.3%)	4 (12.5%)	0.1
Digestive	14 (20.3%)	5 (15.6%)	0.6
Immune	8 (11.6%)	3 (9.4%)	0.7
Reproductive & sexual	1 (1.4%)	0 (0%)	0.5
Endocrine	21 (30.4%)	14 (43.8%)	0.2
Respiratory	58 (81.4%)	25 (78.1%)	0.5
Visual	4 (5.8%)	5 (15.6%)	0.1
Cardiovascular	38 (55.1%)	22 (68.8%)	0.2
Co-morbidities (n)	2 (1 to 4)	4 (2.5 to 5.5)	0.007*
Co-morbidity type (%)
Coronary	14 (20.3%)	19 (59.4%)	<0.001*
Circulatory	34 (49.3%)	19 (59.4%)	0.3
Digestive	10 (14.5%)	5 (16.1%)	0.8
Depression & mood	8 (11.6%)	7 (21.9%)	0.2
Renal	1 (1.4%)	3 (9.4%)	0.06
Immune	8 (11.6%)	1 (3.1%)	0.2
Musculoskeletal	10 (14.5%)	8 (25%)	0.2
Cancer	9 (13%)	3 (9.4%)	0.6
Endocrine	27 (39.1%)	16 (50%)	0.3
Peripheral nerve	2 (2.9%)	2 (6.3%)	0.4
Eye	5 (7.2%)	5 (15.6%)	0.2

^*Indicates significant difference between groups at p<0.05